Saudi Arabia’s Public Investment Fund is set to become an anchor investor in a series of new funds from Goldman Sachs Asset ...
Key Takeaways AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra.AbbVie said it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback